Insulet Corp. Stock
Price
Target price
€153.05
€153.05
-4.030%
-6.3
-4.030%
€215.54
25.04.24 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
Heavy losses for Insulet Corp. today as the stock fell by -€6.300 (-4.030%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Insulet Corp..
As a result the target price of 215 € shows a positive potential of 40.48% compared to the current price of 153.05 € for Insulet Corp..
Pros and Cons of Insulet Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | -4.030% | -1.099% | 0.724% | -47.765% | -22.877% | -35.121% | - |
| Neogen Corp. | - | 0.893% | -18.116% | -27.097% | -38.251% | -71.392% | -56.244% |
| Bio-Rad Labs Inc. A | -0.920% | -2.763% | -18.393% | -35.549% | -12.500% | -51.528% | - |
| Merit Medical Systems | -0.720% | 4.545% | 2.985% | -2.817% | 1.471% | 33.981% | 41.990% |
Comments
Insulet Co. (NASDAQ: PODD) had its price target lowered by analysts at Piper Sandler from $250.00 to $230.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $190.00 to $225.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $238.00 price target on the stock, up previously from $180.00.
Show more
Ratings data for PODD provided by MarketBeat
News
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back.
Investors
